Statistical analysis plan for the LAST ACT clinical trial; a Leukotriene A4 hydrolase Stratified non-inferiority Trial of Adjunctive Corticosteroids for HIV-negative adults with Tuberculous meningitis [version 2; peer review: 2 approved, 1 approved with reservations]

Statistical analysis plan for the LAST ACT clinical trial; a Leukotriene A4 hydrolase Stratified non-inferiority Trial of Adjunctive Corticosteroids for HIV-negative adults with Tuberculous meningitis [version 2; peer review: 2 approved, 1 approved with reservations]

Tuberculous meningitis (TBM) is the most severe form of tuberculosis. Corticosteroids are currently recommended as an adjunctive therapy in HIV-negative adults with TBM. However, benefit from corticosteroids in TBM may depend upon host leukotriene A4 hydrolase (LTA4H) genotype and the corresponding...

Full description

Saved in:
Bibliographic Details
Main Authors: Joseph Donovan, Dong Huu Khanh Trinh, Ronald B. Geskus, Marcel Wolbers, Guy E. Thwaites, Nguyen Thuy Thuong Thuong, Le Thanh Hoang Nhat
Format: Article
Language:English
Published: Wellcome 2025-02-01
Series:Wellcome Open Research
Subjects:
tuberculous meningitis
corticosteroids
clinical trial
analysis plan
leukotriene A4 hydrolase (LTA4H)
personalised medicine
eng
Online Access:https://wellcomeopenresearch.org/articles/9-695/v2
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://wellcomeopenresearch.org/articles/9-695/v2

Similar Items